Wages for Qualified Services

Wages for qualified services represent the taxable compensation paid to employees for their direct involvement in, supervision of, or support for research activities meeting specific technological and experimental criteria. Within the New York regulatory framework, these must be attributable to services performed physically within state borders to qualify as eligible research expenditures for refundable and non-refundable credits.

Foundations of the New York Research and Development Incentive Landscape

The economic architecture of New York State has undergone a profound transformation over the last two decades, shifting from a traditional manufacturing base toward a high-technology, innovation-driven ecosystem. Central to this strategy is the use of targeted tax incentives designed to lower the cost of capital for firms engaged in research and development (R&D). The most critical component of these incentives is the treatment of labor costs, formally recognized as “wages for qualified services.” Because R&D in fields like biotechnology, software engineering, and advanced materials is inherently labor-intensive, the definition and application of what constitutes a “qualified wage” often dictate the entire fiscal viability of a research project in the state.

New York does not maintain a single, monolithic R&D tax credit. Instead, it offers a suite of programs housed within different articles of the Tax Law and administered by distinct agencies. The two primary pillars are the Excelsior Research and Development Tax Credit, which is part of the broader Excelsior Jobs Program, and the Life Sciences Research and Development Tax Credit Program. While both utilize federal definitions as a baseline, they diverge significantly in their calculation methods, eligibility thresholds, and treatment of third-party costs. Understanding the nuances of “wages for qualified services” requires a multi-layered analysis of how state law overlays federal definitions found in the Internal Revenue Code (IRC).

The strategic intent behind these credits is not merely to reward scientific discovery but to ensure that the high-paying jobs associated with that discovery remain within New York’s borders. This is evidenced by the “payroll fraction” and “geographic nexus” requirements that permeate local revenue office guidance. For a business leader or tax professional, the challenge lies in the meticulous documentation of employee activities to prove that their compensation qualifies under both the activity-based tests of IRC § 41 and the location-based tests of New York Tax Law.

The Technical Definition of Wages under Federal and State Conformity

New York’s tax system is generally “coupled” with the federal tax code, meaning it adopts many of the definitions established by the Department of the Treasury and the Internal Revenue Service (IRS). For R&D purposes, New York explicitly references IRC § 41(b) to define qualified research expenses.

Statutory Basis of Compensation

For the purposes of the R&D credit, “wages” are defined by IRC § 3401(a). This is a broad definition that encompasses all remuneration for services performed by an employee for their employer, including the cash value of all remuneration paid in any medium other than cash. In the context of a New York business, this typically includes:

• Base salaries and hourly wages.
• Performance-based bonuses and commissions.
• The spread on the exercise of non-qualified stock options (NSOs), which is treated as ordinary income and reported on the employee’s Form W-2.
• Vacation pay and sick leave, provided they are part of the employee’s taxable compensation.

It is important to note that the definition is limited to taxable wages. Therefore, employer contributions to 401(k) plans, health insurance premiums, and other non-taxable fringe benefits are excluded from the “wages for qualified services” base, even if the employee is a full-time researcher.

Treatment of Equity Compensation and Bonuses

Equity-based compensation represents a significant portion of the “wages” for high-growth startups in New York City’s tech corridor. New York revenue guidance follows the federal lead in allowing the inclusion of stock option redemptions if the employee was engaged in qualified services during the period the options were earned.

Compensation Type	Inclusion in QREs	Tax Treatment
Base Salary	Always (if qualified)	Ordinary Income
Annual Bonus	Included	Ordinary Income
NSO Exercise Spread	Included	Ordinary Income (W-2)
ISO Exercise	Generally Excluded	Capital Gains (unless disqualified)
401(k) Match	Excluded	Non-taxable Benefit
Health Insurance	Excluded	Non-taxable Benefit

Comparative analysis of compensation components in R&D credit base.

The timing of these inclusions can be complex. If an option is granted in Year 1 but exercised in Year 5, the “wages” are recognized in Year 5. However, the employer must look back to Year 1 to determine if the work performed at the time of the grant was a qualified service. For New York residents, these wages are fully taxable and potentially eligible for the credit. For non-residents or part-year residents, the “workday fraction” must be applied to determine how much of that stock option income is attributable to New York-based services.

Qualified Services: The Three Functional Categories

The law requires that wages be paid for “qualified services” to be eligible for the credit. Federal regulations under Treas. Reg. § 1.41-2(d) identify three specific tiers of personnel activity: direct conduct, direct supervision, and direct support.

Direct Conduct of Research

Direct conduct involves the hands-on performance of qualified research. This is the “bench work” of innovation. In a New York context, this includes scientists in a lab in Buffalo, software engineers in a Flatiron District startup, or mechanical engineers prototyping medical devices in Rochester. The employee must be evaluating alternatives and using a process of experimentation to eliminate technical uncertainty.

Direct Supervision of Research

Direct supervision refers to the immediate management of the researchers. This is typically the “one-up” manager who is intimately involved in the technical decision-making process. Local revenue guidance and audit techniques emphasize that this does not include high-level executives who only receive periodic reports on R&D progress. To qualify as direct supervision, the manager must be making real-time adjustments to the research plan, reviewing technical data, and guiding the experimental path.

Direct Support of Research

Direct support involves tasks that are essential to the research but are not technical in nature. The “incident to” rule is the guiding principle here. If the activity is performed specifically for the R&D department and supports a qualified researcher, it may be eligible. Standard examples include:

• A technician who maintains and calibrates a mass spectrometer used in a genomics trial.
• A programmer who maintains the specific server environment used exclusively by the R&D team to run simulations.
• A clerk who enters raw experimental data into a database for analysis by scientists.

Activities that do not qualify as direct support include general corporate functions such as legal, accounting, finance, and human resources. For example, a lawyer drafting a patent application is not performing a qualified service for the R&D credit, even though their work is related to innovation. Similarly, a payroll clerk processing the checks for the R&D team is performing a general administrative function that does not qualify as direct support.

The “Substantially All” Rule and the 80% Threshold

The “substantially all” rule is a crucial administrative provision that allows for the inclusion of 100% of an employee’s wages if at least 80% of their time is dedicated to qualified services. This rule is intended to reduce the burden of tracking every single minute of a dedicated researcher’s day.

Mathematical Application

The calculation follows a binary threshold:

If (Hours in Qualified Services / Total Working Hours) is greater than or equal to 80%, then Qualified Wages = 100% of W-2 Wages.

If (Hours in Qualified Services / Total Working Hours) is less than 80%, then Qualified Wages = Actual % of Time * W-2 Wages.

Formal logic of the 80% rule application.

For a New York startup, this rule can provide a significant boost to the credit amount. If a Chief Technology Officer (CTO) spends 85% of their time on direct coding and technical supervision and 15% on general administrative meetings with the board, the state allows their entire salary to be included in the R&D base. However, if that same CTO’s administrative burden increases to 25% of their time, only 75% of their salary can be claimed. This “all or nothing” jump at the 80% mark makes meticulous time-tracking the most valuable administrative activity a firm can undertake.

Geographic Nexus: The New York Payroll Fraction

New York’s revenue office is strictly protective of the state’s fiscal resources, ensuring that credits are only awarded for work that truly benefits the state’s economy. While federal credits apply to “U.S.-based” research, New York credits are restricted to “New York-based” research.

The Workday Fraction for Non-Residents

In an era of hybrid and remote work, the geographic nexus requirement has become a point of contention. If an employee lives in New Jersey but works at a lab in Manhattan three days a week, their “wages for qualified services” must be apportioned.

The standard formula for New York source income for a nonresident is the ratio of days worked in New York to the total days worked everywhere.

NY Qualified Wages = Total Qualified Wages * (Days Worked in New York / Total Work Days in Year)

Apportionment formula for nonresident R&D wages.

This apportionment must be performed before applying the 80% rule. If an employee works 100% of their time on R&D but is only in New York for 50% of their working days, only 50% of their wages can ever be considered “New York QREs.”

Specific Regional Requirements

The New York City Biotechnology Tax Credit introduces an even more localized requirement. To qualify for the NYC credit, a company must employ 100 or fewer full-time employees, and at least 75% of those employees must be based within the five boroughs of New York City. This creates a concentric circle of geographic requirements: federal (U.S.), state (New York), and city (NYC). A wage that qualifies for the federal credit might fail the state test if the work is out-of-state, and a wage that qualifies for the state credit might fail the city test if the employee is located in Yonkers or Long Island rather than Brooklyn or Manhattan.

The New York Life Sciences R&D Tax Credit Program

The Life Sciences R&D Credit is perhaps the most aggressive incentive offered by the state, specifically designed to compete with biotech hubs like Boston and San Francisco. Administered by Empire State Development (ESD), this program deviates from the standard federal “incremental” model in several key ways.

Fixed-Rate Calculation

Most R&D credits, including the federal credit and the New York Excelsior credit, are “incremental”—they only reward the increase in R&D spending over a historical base period. The Life Sciences credit, however, uses a straightforward fixed-rate method on total New York QREs for the year.

Company Size (Employees)	Credit Rate on Total QREs	Refundability
Fewer than 10	20%	Fully Refundable
10 or more	15%	Fully Refundable

Data on Life Sciences R&D Credit Tiers.

For a pre-revenue biotech startup, this is a transformative benefit. If a firm with 5 employees spends $1 million on qualified wages in its first year, it can receive a cash refund of $200,000 from the state, regardless of whether it has any tax liability.

The “New Business” Constraint

To prevent existing large corporations from simply spinning off departments to claim the credit, the Life Sciences program is strictly limited to “new” businesses. Under New York Tax Law Section 210-b(1)(f), a business is generally considered new if it:

• Has been a taxpayer in New York for five years or less.
• Is not substantially similar in ownership and operation to another company that is or was previously a taxpayer in the state.
• Less than 50% of the company is owned or controlled by another New York taxpayer.

Exclusion of Contract Research

The most significant “trap” in the Life Sciences credit is its treatment of contract research. While the federal credit allows for the inclusion of 65% of payments made to third-party Clinical Research Organizations (CROs), the New York Life Sciences credit explicitly excludes all contract research expenses.

This exclusion places the entire emphasis on “wages for qualified services.” A firm that outsources its clinical trials will find almost none of those costs eligible for the NY Life Sciences credit, whereas a firm that hires its own scientists and lab techs to conduct the same trials in-house will find their entire payroll eligible. This creates a powerful incentive for “in-sourcing” high-skilled labor to New York.

The Excelsior Research and Development Tax Credit

Firms that do not qualify for the Life Sciences program—perhaps because they are not “new” or are in a different industry like software or clean energy—can look to the Excelsior Jobs Program.

Linkage to the Federal Credit

The Excelsior R&D credit is mathematically tethered to the federal benefit. It allows a participant to claim 50% of the portion of their federal R&D tax credit that is attributable to expenditures in New York.

However, the state imposes an overriding cap to maintain fiscal control:

• The credit is capped at 6% of the qualified research expenditures attributable to New York activities.
• For “Qualified Green Projects” or semiconductor “Green CHIPS” projects, the cap is increased to 8%.

Industry and Job Growth Thresholds

Unlike the Life Sciences credit, which only looks at the number of employees to determine the rate, the Excelsior program requires firms to meet specific job creation and investment “tracks.”

Strategic Industry	Minimum Net New Jobs Required
Scientific R&D	5
Software Development	5
Manufacturing	5
Financial Services (Back Office)	25
Distribution	50
Entertainment / Music Production	100

Job creation requirements for Excelsior eligibility.

Under this program, “wages for qualified services” have a dual role. They are used to calculate the R&D credit component, and they are also used to satisfy the “Jobs Tax Credit” component, which provides a credit of up to 6.85% of wages per net new job.

Local Revenue Office Guidance and Interpretive Memoranda

The New York State Department of Taxation and Finance (DTF) issues Technical Services Bureau Memoranda (TSB-Ms) and Advisory Opinions that clarify how these laws are applied in practice. These documents are legally binding on the department and provide the most granular level of guidance available.

Advisory Opinion TSB-A-24(13)I: The 280C “Haircut”

A major administrative hurdle for R&D-performing firms is IRC § 280C(c). Under federal law, if a company claims an R&D credit, it must reduce its business expense deduction for those same R&D costs by the amount of the credit. This prevents a “double benefit” where the government pays for the same research twice (once through a deduction and once through a credit).

For partners in New York partnerships or shareholders in S-Corps, this federal adjustment could lead to higher New York taxable income. However, TSB-A-24(13)I provides a crucial “subtraction modification.” The DTF ruled that under Tax Law § 612(c)(15), individual taxpayers can subtract from their New York adjusted gross income the portion of wages for which a federal deduction was disallowed under § 280C.

This interpretation effectively allows New York taxpayers to receive the full benefit of the federal credit without being penalized on their state income tax return. It ensures that the “wages for qualified services” are treated as fully deductible expenses for state purposes, even if they are restricted at the federal level.

TSB-M-12(9)C: Defining the “Primary Products” Test

For firms seeking the Qualified Emerging Technology Company (QETC) credits, TSB-M-12(9)C clarifies how a business demonstrates it is a technology firm. If a startup has not yet achieved commercial sales, it must prove that at least 50% of its total expenses are “attributable to emerging technologies.”

In this scenario, the payroll for researchers becomes the defining characteristic of the business. If more than half of the company’s payroll consists of “wages for qualified services” in a field like biotechnology or advanced materials, the company is certified as a QETC. This certification then unlocks further employment and capital credits.

Sales Tax Bulletin TB-ST-773: R&D in the Experimental Sense

While the user’s primary concern is wage-based credits, the DTF’s guidance on sales tax provides a definitive list of activities that the state considers “research and development in the experimental or laboratory sense.” This acts as a reliable proxy for what constitutes “qualified services” in an audit.

Activities identified as Qualified:

• Basic research in a technical field.
• Advancing technology in a scientific field.
• Developing or improving new products or existing products.

Activities identified as Non-Qualified:

• Quality control testing or routine inspections.
• Efficiency surveys and management studies.
• Consumer surveys and market research.
• Promotions or advertising.

If an employee’s job description primarily involves quality control or market research, their wages will likely be disallowed during an audit, even if they are trained engineers.

Documentation and Audit Defense: The Battle over Proof

The “meaning” of wages for qualified services is increasingly determined by a company’s ability to produce contemporaneous documentation. Both the IRS and New York DTF have significantly increased their scrutiny of R&D claims, moving away from high-level estimates toward project-specific accounting.

The Shift to Business Component Reporting

Starting in tax year 2024, significant changes to federal Form 6765 (which New York utilizes as a basis for its own credit calculations) will require a detailed breakdown of costs per “business component.” A business component is any product, process, software, or invention that is held for sale or used in the taxpayer’s trade or business.

Under the new reporting regime, taxpayers must provide:

• The name and type of each business component.
• A description of the technical uncertainty and the alternatives evaluated.
• A specific allocation of wages for direct conduct, direct supervision, and direct support to each individual project.

Case Law Lessons

Recent federal court decisions, which serve as influential precedents for New York state tax appeals, highlight the dangers of “biased judgment samples” and inadequate records.

Little Sandy Coal v. Commissioner

The court disallowed an R&D claim because the taxpayer defined its business component as an entire group of vessels. The court ruled that the “80% POE (Process of Experimentation) test” must be applied to the specific sub-components that were actually being researched. Because the taxpayer’s documentation was too broad, it could not prove that substantially all of the labor was dedicated to experimental activities.

Scott Moore v. Commissioner

The court agreed with the IRS in disallowing the wages of a COO that had been included as “direct supervision.” The court noted that the executive was “two layers removed” from the actual researchers. The supervision was categorized as high-level management rather than the hands-on technical guidance required by the “qualified services” definition.

For a New York business, these cases mean that the “title” of an employee is irrelevant. A researcher must be able to show what they actually did during a specific time period.

Practical Case Study: “Apex BioSystems LLC”

To integrate these rules into a cohesive scenario, consider Apex BioSystems, a medical robotics firm based in Brooklyn, NY.

Project Profile: “GigaHand Surgical Prototype”

• Sector: Life Sciences / Medical Devices.
• Entity Type: S-Corporation.
• Benefit Period: Year 2 of ESD Certification.
• Total Employee Count: 12 full-time equivalent (FTE) employees.

Payroll Breakdown and Qualification Analysis

Apex has a total payroll of $1.8 million. The tax team must evaluate each employee’s activity to identify “wages for qualified services.”

Employee	Role	Total W-2	% Qualified Time	Resulting QREs	Analysis
Dr. A	Lead Scientist	$250,000	95%	$250,000	Meets 80% rule; full inclusion.
Eng. B	Senior Engineer	$180,000	75%	$135,000	Fails 80% rule; proportional inclusion.
Eng. C	Senior Engineer	$180,000	85%	$180,000	Meets 80% rule; full inclusion.
Mr. D	Lab Manager	$120,000	90%	$120,000	Direct supervision; meets 80% rule.
Ms. E	Lab Tech	$75,000	100%	$75,000	Direct support; full inclusion.
Mr. F	COO	$300,000	10%	$0	Supervision too remote; fails audit test.
Mr. G	Office Admin	$65,000	100%	$0	General admin is non-qualified.

Total Wages for Qualified Services = $760,000.

Expenditure and Supply Calculation

In addition to wages, Apex incurred costs for lab reagents ($50,000) and prototype materials ($30,000). They also paid a CRO in Pennsylvania $200,000 to run clinical tests.

Total NY QREs for Life Sciences Credit:

• Qualified Wages: $760,000
• Qualified Supplies: $80,000
• Contract Research: $0 (Excluded in NY Life Sciences Credit)
• Total Base = $840,000.

Final Credit Determination

As a company with 12 employees (10 or more), Apex qualifies for the 15% rate.

Credit = $840,000 * 15% = $126,000

Refundable Amount = $126,000.

Because Apex is an S-Corporation, this $126,000 credit is passed through to the individual shareholders. Each shareholder will report their pro-rata share of the credit on their personal IT-201 or IT-203 return. Furthermore, thanks to TSB-A-24(13)I, the shareholders can take a subtraction modification for the federal 280C “haircut” applied to these wages, ensuring they are not double-taxed.

Statistical Overview of New York R&D Tax Expenditures

The scale of New York’s commitment to these incentives is reflected in the state’s fiscal data. The Department of Taxation and Finance tracks these expenditures across Article 9-A (Corporation Franchise) and Article 22 (Personal Income Tax).

Program Utilization Trends (SFY 2021-2025)

The State Fiscal Year (SFY) reports indicate a steady rise in the dollar value of credits issued, driven by both inflation in wages and increased participation in the life sciences initiative.

Fiscal Year	Life Sciences Credit issued ($M)	Excelsior R&D Total ($M)	Average Credit per Recipient
SFY 2021-22	$3.5	$14.2	$85,000
SFY 2022-23	$3.66	$18.2	$92,000
SFY 2023-24	$3.9 (est)	$20.5 (est)	$98,000
SFY 2024-25	$4.2 (forecast)	$24.0 (forecast)	$105,000

Data synthesized from NYS Financial Condition and Tax Expenditure Reports.

The data reveals a striking trend: despite a $10 million annual cap for the Life Sciences program, the state consistently issues less than half of that amount. This “under-subscription” is attributed to the strict “new business” requirement and the administrative complexity of the ESD certification process. Many firms that might qualify for the R&D credit find themselves ineligible because they have been in business for more than five years, forcing them into the lower-rate Excelsior program.

Sector-Specific Impact

In the 2025 recipients report, the “Information” sector (including software development) received the largest amount of R&D tax credit per recipient, averaging approximately $191,000. Within this sector, 87% of the awards went to firms involved in data processing, computer infrastructure, and web hosting—industries where the “wages for qualified services” are exceptionally high.

Navigating the Audit Environment: Common Pitfalls

Local state revenue offices are tasked with ensuring that companies are not “gaming” the system by overstating the time their employees spend on R&D. During an audit, New York examiners often look for specific “red flags.”

Title-Based Qualification

A frequent error is claiming a credit based solely on an employee’s job title. Auditors are trained to investigate the actual work performed. If a “Senior Software Engineer” spends 40% of their time on customer troubleshooting and 30% on legacy code maintenance, only 30% of their wages are qualified, regardless of their impressive title.

The “One-Up” Limitation

The failure to document the technical nature of supervision is a common reason for the disallowance of executive wages. If a CEO is a scientist and supervises the R&D team, their wages qualify. However, if that CEO is a business professional who merely approves the budget for the R&D team, their supervision is administrative, not technical.

Retrospective Estimates

New York DTF generally rejects “retrospective” surveys where employees are asked at the end of the year to estimate how they spent their time. In Eustace v. Commissioner, the court underscored the necessity of contemporaneous records. Firms that do not have a time-tracking system in place at the beginning of the year are at a high risk of having their claims reversed on appeal.

Future Outlook: Amortization and the OBBBA

The landscape of “wages for qualified services” is currently in a state of flux due to shifts in federal policy that automatically impact New York’s conformity.

The Move to Amortization

Between 2022 and 2024, the Tax Cuts and Jobs Act (TCJA) required all R&D wages to be capitalized and amortized over five years. This was a significant blow to the cash flow of New York’s tech firms, as they could no longer deduct their researchers’ salaries in the year they were paid.

Reinstatement of Expensing

The “One Big Beautiful Bill Act” (OBBBA) of 2025 has moved to permanently restore immediate expensing for domestic R&E expenditures under a new Section 174A. For New York businesses, this means that for taxable years beginning after December 31, 2024, “wages for qualified services” will once again be fully deductible in the current year. This shift is expected to trigger a surge in program applications as the “real” value of the credit increases alongside the restored deduction.

Final Thoughts: Strategic Imperatives for New York Innovation

The technical meaning of “wages for qualified services” in New York is the epicenter of the state’s innovation policy. It represents a sophisticated attempt to marry federal scientific definitions with state-level economic protectionism. For the business community, the implications are clear: the path to securing these lucrative refundable credits is paved with data, not just discovery.

To maximize the benefit of New York’s R&D incentives, firms must adopt a “culture of compliance” that begins in the lab and ends in the accounting office. This includes:

1. Granular Time Tracking: Moving beyond simple estimates to contemporaneous, project-linked labor logs.
2. Strategic Geographic Placement: Ensuring that high-value R&D activities are physically anchored within New York facilities to avoid workday fraction reductions.
3. Active Supervision Management: Documenting the technical (rather than corporate) nature of management’s involvement in the R&D cycle.
4. Tax Law Monitoring: Leveraging recent guidance like TSB-A-24(13)I to shield individual partners and shareholders from federal “double-taxation” penalties.

As New York’s fiscal year forecasts suggest continued growth in the innovation sector, the scrutiny from the Department of Taxation and Finance will only intensify. By mastering the nuanced definition of qualified wages and the services they compensate, New York’s trailblazing enterprises can effectively transform their payroll from an overhead burden into a strategic asset that fuels the next generation of scientific breakthroughs.